Elanix Biotechnologies AG (DB: ELN) Founder and Interim-Chief Executive Officer, Lee Ann Laurent-Applegate notified company that she intends to sell and transfer a total of 1.4 million shares of company, purchase price of the shares is €1. Sale will be to a potential strategic investor.